Marinomed Biotech AG
Develops treatments for viral infectious diseases and immunological disorders.
MARI | VI
Overview
Corporate Details
- ISIN(s):
- ATMARINOMED6
- LEI:
- 529900GN3B1EN80XF405
- Country:
- Austria
- Address:
- Hovengasse 25, 2100 Korneuburg
- Website:
- https://www.marinomed.com/en
- Sector:
- Manufacturing
Description
Marinomed Biotech AG is a biopharmaceutical company that develops medicinal products and medical devices for viral infectious diseases and immunological disorders. The company's innovation is driven by proprietary, patent-protected technology platforms. The Marinosolv platform enhances the solubility and bioavailability of poorly soluble compounds, enabling the development of treatments for immunological conditions such as allergies, asthma, and inflammatory diseases. The virology platform is the basis for therapies targeting viral respiratory infections. Marinomed maintains a development pipeline, has globally marketed therapeutics, and offers its technology through partnerships and services via its Solv4U unit.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-31 10:01 |
EQS-NVR: Marinomed Biotech AG: Release according to Article 135, Section 1 Börs…
|
English | 16.5 KB | ||
| 2025-10-31 10:01 |
EQS-NVR: Marinomed Biotech AG: Veröffentlichung der Gesamtstimmrechte nach § 13…
|
German | 17.0 KB | ||
| 2025-10-31 10:00 |
Release according to Article 135, Section 1 BorseG with the objective of Europe…
|
English | 3.6 KB | ||
| 2025-10-06 14:58 |
EQS-Adhoc: Marinomed Biotech AG begins reviewing strategic options for the Mari…
|
English | 34.6 KB | ||
| 2025-10-06 14:58 |
EQS-Adhoc: Marinomed Biotech AG startet Prüfung strategischer Optionen für die …
|
German | 36.4 KB | ||
| 2025-10-06 14:56 |
Marinomed Biotech AG begins reviewing strategic options for the Marinosolv plat…
|
English | 11.1 KB | ||
| 2025-09-17 13:48 |
Marinomed Biotech AG announces results for the first half year of 2025
|
English | 10.6 KB | ||
| 2025-09-17 13:42 |
EQS-AFR: Marinomed Biotech AG: Release of a Financial report
|
English | 3.4 MB | ||
| 2025-09-17 13:42 |
EQS-AFR: Marinomed Biotech AG: Bekanntmachung über die Veröffentlichung eines F…
|
German | 3.5 MB | ||
| 2025-09-16 15:24 |
EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory s…
|
English | 31.7 KB | ||
| 2025-09-16 15:24 |
EQS-Adhoc: Marinomed Biotech AG beschließt Kapitalerhöhung unter Bezugsrechtsau…
|
German | 33.7 KB | ||
| 2025-09-16 15:22 |
Marinomed Biotech AG resolves capital increase excluding statutory subscription…
|
English | 8.0 KB | ||
| 2025-09-02 09:18 |
EQS-AGM: Marinomed Biotech AG: Convening of an Extraordinary General Meeting fo…
|
English | 51.6 KB | ||
| 2025-09-02 09:17 |
EQS-HV: Marinomed Biotech AG: Einberufung einer außerordentlichen Hauptversamml…
|
German | 50.1 KB | ||
| 2025-09-02 09:16 |
Marinomed Biotech AG: Convening of an Extraordinary General Meeting for Tuesday…
|
English | 21.9 KB |
Automate Your Workflow. Get a real-time feed of all Marinomed Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Marinomed Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Marinomed Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
